Nebivolol/valsartanAlternative Names: Byvalson; Valsartan/nebivolol
Latest Information Update: 08 Jun 2016
At a glance
- Originator Forest Laboratories
- Developer Allergan
- Class Antihypertensives; Benzopyrans; Ethanolamines; Ischaemic heart disorder therapies; Tetrazoles
- Mechanism of Action Angiotensin type 1 receptor antagonists; Beta 1 adrenergic receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Registered Essential hypertension